Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes

Toxicology in Vitro

Volumn 25, Issue 3, 2011, Pages 652-656

  Dvořák, Zdeněk ^a   Štarha, Pavel ^a   Trávníček, Zdeněk ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

6 Benzylaminopurine derivative; Carboplatin derivative; CDK inhibitor; Cytotoxicity; Human hepatocytes

Indexed keywords

6 N BENZYLADENINE; CARBOPLATIN; CISPLATIN; OXALIPLATIN; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (2 FLUORO 5 BROMOBENZYL)AMINO 9 ISOPROPYLURINE)2; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (2 TRIFLUOROMETHYLBENZYL)AMINO 9 ISOPROPYLPURINE)2; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (3 BROMOBENZYL)AMINO 9 ISOPROPYLPURINE)2; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (3 TRIFLUOROMETHYLBENZYL)AMINO 9 ISOPROPYLPURINE)2; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (3,4 DICHLOROBENZYL)AMINO 9 ISOPROPYLURINE)2; PLATINUM (CYCLOBUTANE 1,1 DICARBOXYLATO COMPLEX)(2 CHLORO 6 (4 TRIFLUOROMETHYLBENZYL)AMINO 9 ISOPROPYLPURINE)2; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL; LUNG CARCINOMA; MALE; MELANOMA; OSTEOSARCOMA; OVARY CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HEPATOCYTES; HUMANS; KINETIN; MALE; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 79952036601     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.01.002     Document Type: Article

References (13)

1. Bitha P., Morton G.O., Dunne T.S., Delos Santos E.F., Lin Y., Boone S.R., Haltiwanger R.C., Pierpoint C.G. (Malonato)bis[sulfinylbis[methane]-S]platinum(II) compounds: versatile synthons for a new general synthesis of antitumor symmetrical and dissymmetrical (Malonato)platinum(II) complexes. Inorganic Chemistry 1990, 29:645-652.
2. Bose R.N., Maurmann L., Mishur R.J., Yasui L., Gupta S., Grayburn W.S., Hofstetter H., Salley T. Non-DNA-binding platinum anticancer agents: cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells. PNAS 2008, 105:18314-18319.
3. Diakos C.I., Zhang M., Beale P.J., Fenton R.R., Hambley T.W. Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtCl2(R-dimepyrr)] (R-dimepyrr = N-dimethyl-2(R)-aminomethylpyrrolidine). European Journal of Medicinal Chemistry 2009, 44:2807-2814.
4. Dvořák L., Popa I., Štarha P., Trávníček Z. In vitro cytotoxic active platinum(ii) complexes derived from carboplatin and involving purine derivatives. European Journal of Inorganic Chemistry 2010, 3441:3448.
5. Kelland L.-R., Farrell N.-P. Platinum-based Drugs in Cancer Therapy 2000, Humana Press, Totowa, New Jersey.
6. Maloň M., Trávníček Z., Marek R., Strnad M. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2, 9-disubstituted-6-benzylaminopurines. Journal of Inorganic Biochemistry 2005, 99:2127-2138.
7. Marqués-Gallego P., Kalayda G.V., Jaehde U., den Dulk H., Brouwer J., Reedijk J. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands. Journal of Inorganic Chemistry 2009, 103:791-796.
8. Oh C.H., Lee S.C., Lee K.S., Woo E.R., Hong C.Y., Yang B.S., Baek D.J., Cho J.H. Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor. Archiv der Pharmazie 1999, 332:187-190.
9. Pantoja E., Gallipoli A., van Zutphen S., Tooke D.M., Spek A.L., Navarro-Ranninger C., Reedijk J. In vitro antitumor activity and interaction with DNA model bases of cis-[PtCl2(iPram)(azole)] complexes and comparison with their trans analogues. Inorganica Chimica Acta 2006, 359:4335-4342.
10. Pichard-Garcia L., Gerbal-Chaloin S., Ferrini J.B., Fabre J.M., Maurel P. Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression. Methods in Enzymology 2002, 357:311-321.
11. Štarha P., Trávníček Z., Popa I. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity. Journal of Inorganic Biochemistry 2010, 104:639-647.
12. Trávníček Z., Štarha P., Popa I., Vrzal R., Dvořák Z. Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity. European Journal of Medicinal Chemistry 2010, 45:4609-4614.
13. Vrzal R., Štarha P., Dvořák Z., Trávníček Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(ii) and palladium(ii) oxalato complexes with adenine derivatives as carrier ligands. Journal of Inorganic Biochemistry 2010, 104:1130-1132.